HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gerard B Fox Selected Research

5-(2-azetidinylmethoxy)-2-chloropyridine

10/2011Potentiation of analgesic efficacy but not side effects: co-administration of an α4β2 neuronal nicotinic acetylcholine receptor agonist and its positive allosteric modulator in experimental models of pain in rats.
12/2006Pharmacological MRI in awake rats reveals neural activity in area postrema and nucleus tractus solitarius: relevance as a potential biomarker for detecting drug-induced emesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gerard B Fox Research Topics

Disease

8Cognitive Dysfunction
10/2012 - 06/2003
8Schizophrenia (Dementia Praecox)
04/2012 - 04/2002
8Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
04/2007 - 04/2002
7Neoplasms (Cancer)
01/2017 - 07/2009
5Alzheimer Disease (Alzheimer's Disease)
05/2012 - 04/2002
4Pain (Aches)
01/2013 - 03/2008
2Glioma (Gliomas)
08/2013 - 04/2012
2Wounds and Injuries (Trauma)
01/2013 - 03/2003
2Neuralgia (Stump Neuralgia)
10/2011 - 01/2009
2Hyperalgesia
10/2011 - 01/2009
2Vomiting
03/2011 - 12/2006
2Neurodegenerative Diseases (Neurodegenerative Disease)
07/2008 - 03/2008
2Nervous System Diseases (Neurological Disorders)
08/2004 - 06/2003
1Osteoarthritis
01/2013
1Colorectal Neoplasms (Colorectal Cancer)
10/2012
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2012
1Genetic Predisposition to Disease (Genetic Predisposition)
05/2012
1Postoperative Pain
10/2011
1Carcinoma (Carcinomatosis)
07/2011
1Fibrosarcoma
07/2011
1Brain Diseases (Brain Disorder)
03/2011
1Nausea
03/2011
1Neurocognitive Disorders (Clerambault Syndrome)
03/2008
1Substance-Related Disorders (Drug Abuse)
03/2008
1Sexually Transmitted Diseases (Sexually Transmitted Disease)
01/2007
1Hyperthermia
08/2006
1Body Weight (Weight, Body)
08/2006
1Mood Disorders (Mood Disorder)
07/2006
1Dementia (Dementias)
04/2006
1Obesity
04/2006
1Sleep Wake Disorders
04/2006
1Neural Tube Defects (Exencephaly)
09/2005
1Seizures (Absence Seizure)
09/2005

Drug/Important Bio-Agent (IBA)

7Pharmaceutical PreparationsIBA
01/2017 - 03/2003
6Histamine H3 Receptors (Histamine H3 Receptor)IBA
04/2006 - 06/2003
4linifanibIBA
08/2013 - 07/2011
4Histamine (Histamine Dihydrochloride)FDA Link
10/2012 - 04/2002
3Neurotransmitter Agents (Neurotransmitter)IBA
10/2012 - 06/2003
3Biomarkers (Surrogate Marker)IBA
06/2012 - 12/2006
3Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
10/2011 - 03/2008
3ciproxifanIBA
04/2007 - 05/2005
3Methylphenidate (Ritalin)FDA LinkGeneric
08/2006 - 04/2002
3Histamine H3 AntagonistsIBA
04/2006 - 08/2004
2Glucose (Dextrose)FDA LinkGeneric
10/2012 - 05/2012
2Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
04/2012 - 07/2011
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
04/2012 - 07/2011
2Antipsychotic Agents (Antipsychotics)IBA
04/2012 - 05/2005
25-(2-azetidinylmethoxy)-2-chloropyridineIBA
10/2011 - 12/2006
2imidazoleIBA
08/2006 - 05/2005
24- (2- (2- ((2r)- 2- methyl- 1- pyrrolidinyl)ethyl)- 5- benzofuranyl)- benzonitrile (ABT 239)IBA
05/2005 - 04/2005
1technetium 99m (HYNIC-3PRGD(2))(tricine)(TPPTS)IBA
08/2013
1IntegrinsIBA
08/2013
1Celecoxib (Celebrex)FDA Link
01/2013
1salicylhydroxamic acid (SHAM)IBA
01/2013
1Matrix Metalloproteinases (MMPs)IBA
01/2013
12-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA
01/2013
1Matrix Metalloproteinase InhibitorsIBA
01/2013
1Irinotecan (Camptosar)FDA LinkGeneric
10/2012
1ThymidineIBA
10/2012
1Tyrosine Kinase InhibitorsIBA
04/2012
1Aligeron (AS 2)IBA
04/2012
1KetamineFDA LinkGeneric
04/2012
1Analgesics (Analgesic Drugs)IBA
10/2011
13- (3- (pyridine- 3- yl)- 1,2,4- oxadiazol- 5- yl)benzonitrileIBA
10/2011
1CarrageenanIBA
10/2011
1Acetates (Acetic Acid Esters)FDA Link
10/2011
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
07/2011
1Proteins (Proteins, Gene)FDA Link
07/2011
1ManganeseIBA
05/2011
1Methylazoxymethanol AcetateIBA
05/2011
1Acetylcholine (Acetylcholine Chloride)FDA Link
03/2011
1TubulinIBA
07/2009
1ABT751IBA
07/2009
1A-836339IBA
01/2009
1Freund's AdjuvantIBA
01/2009
1AmidesIBA
01/2009
1CB2 Cannabinoid ReceptorIBA
01/2009
1Capsaicin (Zostrix)FDA Link
01/2009
1CannabinoidsIBA
01/2009
1cyclopropanecarboxylic acidIBA
01/2009
1mu Opioid Receptors (mu Opioid Receptor)IBA
01/2009
1Nootropic Agents (Nootropics)IBA
07/2008
1NicotineFDA Link
04/2007
1Scopolamine (Hyoscine)FDA Link
01/2007
1Dizocilpine Maleate (Dizocilpine)IBA
01/2007
1Contrast MediaIBA
12/2006
1EmeticsIBA
12/2006
1ApomorphineFDA Link
12/2006
1LigandsIBA
08/2006
14- ((3- (4- (2- aminopropanoyl)- 1- piperazinyl)propoxy)phenyl)cyclopropylmethanoneIBA
08/2006
1melanin-concentrating hormone (melanin concentrating hormone)IBA
07/2006
1Biological ProductsIBA
04/2006
1Dopamine D4 Receptors (Dopamine D4 Receptor)IBA
09/2005
1N- ((4- (2- cyanophenyl)- 1- piperazinyl)methyl)- 3- methylbenzamideIBA
09/2005
1ABT-769IBA
09/2005

Therapy/Procedure

8Therapeutics
08/2013 - 05/2005
1Intraperitoneal Injections
10/2012
1Aftercare (After-Treatment)
07/2011
1Immunotherapy
12/2010
1Drug Therapy (Chemotherapy)
07/2009